期刊文献+

迟发性运动障碍患者血清尿酸及总胆红素的变化及其临床意义 被引量:1

The chanages and clinical significance of serum uric acid and total bilirubin level in patients with tardive dyskinesia.
下载PDF
导出
摘要 目的探讨抗精神病药所致迟发性运动障碍(TD)患者体内尿酸及总胆红素水平与TD的关系。方法测定65例TD(TD组)、58例非TD(非TD组)慢性精神分裂症患者及42名正常人(对照组)血清尿酸及总胆红素浓度,并与异常不自主运动量表(AIMS)总分间的相关性采用直线相关分析。结果TD组血尿酸水平低于对照组(P<0.01)及非TD组(P<0.05),TD组不同性别血尿酸水平对比差异无显著性(P>0.05)。TD组总胆红素水平低于对照组(P<0.05)。血尿酸及总胆红素水平与PD患者的病情轻重无明显相关性(r=-0.26及-0.31,P>0.05),血尿酸及总胆红素水平之间无明显相关性(r=0.33,P>0.05)。结论血清尿酸及总胆红素水平与TD的发生有一定的关系。 Objective To investigate the changes of serum uric acid and total bilirubin level in patients with tardive dyskinesia(TD) and their relationship with TD. Methods The serum levels of uric acid and total bilirubin in normal volunteers( n = 42), schizophrenic patients with TD ( n = 65 ) and schizophrenic patients without TD ( non - TD, n = 58 ) were assayed. Results The serum level of uric acid in patients with TD was significantly lower than those in normal controls ( P 〈0.01 ) and non - TD group( P 〈0.05) . There was no significant gender difference of the serum uric acid level in patients with TD( P 〉 0.05). The serum level of total bilirubin in patients with TD was significantly lower than that in normal controls ( P 〈 0.05 ). The correlation coefficients between the serum uric acid , total bilirubin level and to- tal score of AIMS in patients with TD were -- 0.26and -0.31 ( P 〉0.05). There was no significant relation between the serum uric acid and total bilirubin level in patients with TD ( r = 0.33, P 〉 0.05 ). Conclusion The serum uric acid and total bilirubin may be involved in the development of TD.
出处 《精神医学杂志》 2009年第5期363-365,共3页 Journal of Psychiatry
关键词 迟发性运动障碍 尿酸 总胆红素 精神分裂症 Tardive dyskinesia Uric acid Total bilirubin Schizophrenia
  • 相关文献

参考文献10

  • 1Simpson GM. The treatment of tardive dyskinesia and dystonia [J]. Clin Psychiatry , 2000,16:39-44.
  • 2Elkashef AM, Wyatt RJ. Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E[ J ]. Sehizophr Bul, 1999,25:731 - 740.
  • 3Duan W, Ladenheim B, Cutler RG, et al. Dietary folate deficiencey and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinsons disease [ J ]. Mov Disord , 2003,18:969 - 976.
  • 4Diousse L,Lery D,Cupples LA, et al. Total serum bilinbin and risk of cardiovcscular disease in the tramingham off sping study [ J ]. The American Journal of cardiology,2001,87 (10) : 1196.
  • 5Schooler NR, Kane JM. Research diagnoses for tardive dyskinesial J]. Arch Gen Psychiatry, 1982,39:486 - 487.
  • 6Lohr JB, Kuczenski R, Bracha HS, et al. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia[ J ]. Biol Psychiatry, 1990,28 : 535 - 539.
  • 7Munyon WH, Salo R, Briones DF. Cytotoxic efects of neuroleptic Drugs[ J ] . Psychophannacology ( Bed), 1987,91 : 182--188.
  • 8Andreassen OA, Jorgensen HA. Neurotoxicity associated with neuroleptic--induced oral dyskinesias in rats. Implications for tardive dyskinesia[ J] ? Prog Neurobiol,2000,61:525 -541.
  • 9谭云龙,周东丰,曹连元,邹义壮,张向阳,苏建民.抗精神病药所致迟发性运动障碍患者血浆超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化酶活性及丙二醛浓度的改变[J].中华精神科杂志,2005,38(3):142-145. 被引量:15
  • 10李守霞,赵素斌,杨建英,秦冰.冠心病患者血清胆红素、尿酸水平含量及临床价值[J].临床荟萃,2006,21(7):482-483. 被引量:13

二级参考文献18

  • 1谭云龙,周东丰,邹义壮,车向宜.维生素E对迟发性运动障碍模型大鼠的影响[J].中华精神科杂志,2004,37(3):179-181. 被引量:11
  • 2韩榜成.胆红素的抗氧化性与冠心病的关系[J].国外医学(临床生物化学与检验学分册),1996,17(2):56-58. 被引量:13
  • 3戴自英.实用内科学[M](第9版)[M].北京:人民卫生出版社,1993.1385-1388.
  • 4Glazer WM, Morgenstern H, Schooler N, et al. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication. Br J Psychiatry, 1990, 157:585-592.
  • 5Yassa R, Jeste DV. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull, 1992, 18:701-715.
  • 6Elkashef AM, Wyatt RJ. Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E. Schizophr Bull, 1999,25:731-740.
  • 7Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia.Arch Gen Psychiatry, 1982, 39:486-487.
  • 8Lohr JB, Kuczenski R, Bracha HS, et al. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatry, 1990, 28:535-539.
  • 9Munyon WH, Salo R, Briones DF. Cytotoxic effects of neuroleptic drugs. Psychopharmacology (Berl), 1987, 91:182-188.
  • 10Andreassen OA, Jorgensen HA. Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? Prog Neurobiol, 2000, 61:525-541.

共引文献26

同被引文献16

  • 1谭云龙,周东丰,管振全,曹连元,邹义壮,苏建民.迟发性运动障碍患者血清泌乳素浓度分析[J].中国心理卫生杂志,2005,19(7):463-465. 被引量:3
  • 2Dean C E,Thuras P D. Mortality and tardive dyskinesiaLong-term study using the US National Death Index[J]. Br J Psychiatry, 2009, 194(4) :360-364.
  • 3Tenback D E,van Harten P N,Slooff C J,et al. Incidence and persis- tence of tardive dyskinesia and extra- pyramidal symptoms in schizophrenia[J]. J Psychopharmacol, 2010,24 (7) : 1031-1035.
  • 4Guerreiro S, Ponceau A, Toulorge D, et al. Protection of mibrain dopaminergic neurons by the end product of purine metabolism uric acid: Potentiation by low level depolarization [J]. J Neurochem, 2009,109 (10) : 1118-1198.
  • 5Schooler N R, Kane J M. Research diagnoses for tardive dyskinesia [J]. Arch Gen Psychiatry, 1982,39 (4) t 486-487.
  • 6Nagatsu T, Sawada M. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: Possible implications of glial cells['J]. J Neural Transm, 2006, (Suppl 71 ) : 53-65.
  • 7Jenner P. Oxidative stress in Parkinson's disease[J]: Ann Neurol, 2003,53(Suppl 3) :s26-36.
  • 8Andresen O A,Ferrante R J,Aamo T O,et al. Oral dyskinesias and histopathological alterations in substantia nigra after long--termhaloperidol treatment of old rats[-J]. Neuroseience, 2003,122 (3) : 717-725.
  • 9张文跃,顾凤华,谢立,韩晓东,宣春明.迟发性运动障碍与血清尿酸的关系[J].临床精神医学杂志,2008,18(2):107-108. 被引量:4
  • 10罗蔚锋,刘春风.尿酸水平与帕金森病[J].中华神经科杂志,2008,41(8):552-553. 被引量:16

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部